These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

169 related articles for article (PubMed ID: 30931808)

  • 1. Relapsing lumbosacral myeloradiculitis: An unusual presentation of MOG antibody disease.
    Sundaram S; Nair SS; Jaganmohan D; Unnikrishnan G; Nair M
    Mult Scler; 2020 Apr; 26(4):509-511. PubMed ID: 30931808
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Characterization of the human myelin oligodendrocyte glycoprotein antibody response in demyelination.
    Tea F; Lopez JA; Ramanathan S; Merheb V; Lee FXZ; Zou A; Pilli D; Patrick E; van der Walt A; Monif M; Tantsis EM; Yiu EM; Vucic S; Henderson APD; Fok A; Fraser CL; Lechner-Scott J; Reddel SW; Broadley S; Barnett MH; Brown DA; Lunemann JD; Dale RC; Brilot F;
    Acta Neuropathol Commun; 2019 Sep; 7(1):145. PubMed ID: 31481127
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Two cases of myelin oligodendrocyte glycoprotein antibody-associated disease presenting with Cauda Equina Syndrome without conus myelitis.
    Kang MS; Kim MK; Kim YE; Kim JH; Kim BJ; Lee HL
    Mult Scler Relat Disord; 2021 Jul; 52():103017. PubMed ID: 34023773
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Serial Anti-Myelin Oligodendrocyte Glycoprotein Antibody Analyses and Outcomes in Children With Demyelinating Syndromes.
    Waters P; Fadda G; Woodhall M; O'Mahony J; Brown RA; Castro DA; Longoni G; Irani SR; Sun B; Yeh EA; Marrie RA; Arnold DL; Banwell B; Bar-Or A;
    JAMA Neurol; 2020 Jan; 77(1):82-93. PubMed ID: 31545352
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Myelin oligodendrocyte glycoprotein and aquaporin-4 antibodies are highly specific in children with acquired demyelinating syndromes.
    Duignan S; Wright S; Rossor T; Cazabon J; Gilmour K; Ciccarelli O; Wassmer E; Lim M; Hemingway C; Hacohen Y
    Dev Med Child Neurol; 2018 Sep; 60(9):958-962. PubMed ID: 29468668
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Effects of the Positive Threshold and Data Analysis on Human MOG Antibody Detection by Live Flow Cytometry.
    Tea F; Pilli D; Ramanathan S; Lopez JA; Merheb V; Lee FXZ; Zou A; Liyanage G; Bassett CB; Thomsen S; Reddel SW; Barnett MH; Brown DA; Dale RC; Brilot F;
    Front Immunol; 2020; 11():119. PubMed ID: 32117270
    [TBL] [Abstract][Full Text] [Related]  

  • 7. B Cell, Th17, and Neutrophil Related Cerebrospinal Fluid Cytokine/Chemokines Are Elevated in MOG Antibody Associated Demyelination.
    Kothur K; Wienholt L; Tantsis EM; Earl J; Bandodkar S; Prelog K; Tea F; Ramanathan S; Brilot F; Dale RC
    PLoS One; 2016; 11(2):e0149411. PubMed ID: 26919719
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased interleukin-6 correlates with myelin oligodendrocyte glycoprotein antibodies in pediatric monophasic demyelinating diseases and multiple sclerosis.
    Horellou P; Wang M; Keo V; Chrétien P; Serguera C; Waters P; Deiva K
    J Neuroimmunol; 2015 Dec; 289():1-7. PubMed ID: 26616865
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Encephalitis is an important clinical component of myelin oligodendrocyte glycoprotein antibody associated demyelination: a single-center cohort study in Shanghai, China.
    Wang L; ZhangBao J; Zhou L; Zhang Y; Li H; Li Y; Huang Y; Wang M; Lu C; Lu J; Zhao C; Quan C
    Eur J Neurol; 2019 Jan; 26(1):168-174. PubMed ID: 30133068
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Chronic relapsing inflammatory optic neuropathy (CRION): a manifestation of myelin oligodendrocyte glycoprotein antibodies.
    Lee HJ; Kim B; Waters P; Woodhall M; Irani S; Ahn S; Kim SJ; Kim SM
    J Neuroinflammation; 2018 Oct; 15(1):302. PubMed ID: 30382857
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Usefulness of MOG-antibody titres at first episode to predict the future clinical course in adults.
    Cobo-Calvo A; Sepúlveda M; d'Indy H; Armangué T; Ruiz A; Maillart E; Papeix C; Audoin B; Zephir H; Biotti D; Ciron J; Durand-Dubief F; Collongues N; Ayrignac X; Labauge P; Thouvenot E; Montcuquet A; Deschamps R; Solà-Valls N; Llufriu S; Blanco Y; de Seze J; Vukusic S; Saiz A; Marignier R; ;
    J Neurol; 2019 Apr; 266(4):806-815. PubMed ID: 30607536
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Case Report: Myelin Oligodendrocyte Glycoprotein Antibody-Associated Disorder Masquerading as Multiple Sclerosis: An Under-Recognized Entity?
    Zheng Y; Cai MT; Li EC; Fang W; Shen CH; Zhang YX
    Front Immunol; 2021; 12():671425. PubMed ID: 34220818
    [TBL] [Abstract][Full Text] [Related]  

  • 13. MOG-related disorders: A new cause of imaging-negative myelitis?
    Macaron G; Ontaneda D
    Mult Scler; 2020 Apr; 26(4):511-515. PubMed ID: 30931813
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Associations of paediatric demyelinating and encephalitic syndromes with myelin oligodendrocyte glycoprotein antibodies: a multicentre observational study.
    Armangue T; Olivé-Cirera G; Martínez-Hernandez E; Sepulveda M; Ruiz-Garcia R; Muñoz-Batista M; Ariño H; González-Álvarez V; Felipe-Rucián A; Jesús Martínez-González M; Cantarín-Extremera V; Concepción Miranda-Herrero M; Monge-Galindo L; Tomás-Vila M; Miravet E; Málaga I; Arrambide G; Auger C; Tintoré M; Montalban X; Vanderver A; Graus F; Saiz A; Dalmau J;
    Lancet Neurol; 2020 Mar; 19(3):234-246. PubMed ID: 32057303
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical spectrum and IgG subclass analysis of anti-myelin oligodendrocyte glycoprotein antibody-associated syndromes: a multicenter study.
    Mariotto S; Ferrari S; Monaco S; Benedetti MD; Schanda K; Alberti D; Farinazzo A; Capra R; Mancinelli C; De Rossi N; Bombardi R; Zuliani L; Zoccarato M; Tanel R; Bonora A; Turatti M; Calabrese M; Polo A; Pavone A; Grazian L; Sechi G; Sechi E; Urso D; Delogu R; Janes F; Deotto L; Cadaldini M; Bianchi MR; Cantalupo G; Reindl M; Gajofatto A
    J Neurol; 2017 Dec; 264(12):2420-2430. PubMed ID: 29063242
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Bilateral extensive corticospinal tract lesions in MOG antibody-associated disease.
    Mastrangelo V; Asioli GM; Foschi M; Padroni M; Pavolucci L; Cenni P; Querzani P
    Neurology; 2020 Oct; 95(14):648-649. PubMed ID: 32817179
    [No Abstract]   [Full Text] [Related]  

  • 17. Persistent MOG-IgG positivity is a predictor of recurrence in MOG-IgG-associated optic neuritis, encephalitis and myelitis.
    Oliveira LM; Apóstolos-Pereira SL; Pitombeira MS; Bruel Torretta PH; Callegaro D; Sato DK
    Mult Scler; 2019 Dec; 25(14):1907-1914. PubMed ID: 30417715
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Clinical features of demyelinating optic neuritis with seropositive myelin oligodendrocyte glycoprotein antibody in Chinese patients.
    Zhao Y; Tan S; Chan TCY; Xu Q; Zhao J; Teng D; Fu H; Wei S
    Br J Ophthalmol; 2018 Oct; 102(10):1372-1377. PubMed ID: 29363529
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Unilateral cerebral cortical encephalitis with epilepsy: a possible special phenotype of MOG antibody-associated disorders.
    Tao R; Qin C; Chen M; Yu HH; Wu LJ; Bu BT; Tian DS
    Int J Neurosci; 2020 Nov; 130(11):1161-1165. PubMed ID: 31971044
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Myelin oligodendrocyte glycoprotein antibody-associated disease: an immunopathological study.
    Takai Y; Misu T; Kaneko K; Chihara N; Narikawa K; Tsuchida S; Nishida H; Komori T; Seki M; Komatsu T; Nakamagoe K; Ikeda T; Yoshida M; Takahashi T; Ono H; Nishiyama S; Kuroda H; Nakashima I; Suzuki H; Bradl M; Lassmann H; Fujihara K; Aoki M;
    Brain; 2020 May; 143(5):1431-1446. PubMed ID: 32412053
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 9.